Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 307 followers
Latest posts
Last updated about 2 hours ago
‘Emergency’ at Apple Tree: VC sues key investor, warns portfolio biotechs are on brink of collapse
about 2 hours ago
Apple Tree Partners’ life sciences venture fund has filed litigation against its...
Orphan Cures Act re-added to Trump tax bill as Senate prepares to begin vote-a-rama
about 4 hours ago
The Orphan Cures Act has been added back into the Senate version...
Amgen’s FGFR2b-targeting cancer candidate boosts overall survival in phase 3
about 7 hours ago
Amgen’s investigational monoclonal antibody paired with chemotherapy significantly improved overall survival for...
Pfizer expands AI-powered small-molecule discovery collab with XtalPi
about 8 hours ago
Pfizer has added another chapter to its long-running drug discovery collaboration with...
AbbVie reels in Capstan in $2.1B buyout, charting course for in vivo CAR-T market
about 8 hours ago
AbbVie is making a full strength play for the in vivo CAR-T...
INmune flunks phase 2 Alzheimer's trial, focuses on subgroup efficacy to fuel partnering plans
about 9 hours ago
A phase 2 study of INmune Bio’s TNF inhibitor in Alzheimer’s disease...
Moderna's mRNA flu vaccine beats approved competitor in latest phase 3 win, teeing up push to FDA
about 10 hours ago
The long and winding journey of Moderna’s mRNA flu vaccine toward regulators...
Pliant ends lung disease program after assessing rise in adverse events from bexotegrast trial
about 13 hours ago
Pliant Therapeutics has terminated its idiopathic pulmonary fibrosis (IPF) program after digging...
Glaukos nets European green lights for glaucoma surgery micro-stents
3 days ago
Glaukos said the approvals were its first under the European Union’s new...
CytoDyn must face investor lawsuit alleging misleading claims in COVID, HIV drug debacle
3 days ago
Investors sued CytoDyn and former executives for allegedly misleading shareholders on the...
FDA broadens reach of GE HealthCare's amyloid imaging agent Vizamyl in Alzheimer's diagnostics
3 days ago
The imaging agent can be used to deliver quantitative assessments such as...
Turnstone, once allied with AbbVie and Takeda, accepts $8M Xoma buyout
3 days ago
Turnstone Biologics has limped to the exit. Xoma Royalty is buying Turnstone...